• $6.4B
    Market Cap
  • -30.38%
    1-Year Change
  • Medical Instruments & Supplies
    Industry

Key Performance

More
  • Earnings Score: 37
  • Momentum Score: 31
  • True Yield: N/A
  • Financial Health Score: 6
TradeSmith Loading

Latest Research & News

EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks

The Iran-Israel conflict and potential Strait of Hormuz disruption are creating supply chain pressures on medical supplies through petrochemical derivatives. Key inputs like naphtha and methanol used in pharmaceutical packaging and drug synthesis are experiencing price increases. While hospitals haven't yet felt the impact, analysts expect cost pressures on IV bags, tubing, and other critical consumables to surface within 2-4 weeks as the disruption ripples through supply chains.

03/25/2026, 8:01 AMBenzinga

Looking For A Rebound? China Tech and Emerging Markets Top Oversold List

Multiple China-focused stocks and emerging market ETFs have fallen into deeply oversold territory with exceptionally low RSI readings, potentially setting up for sharp rebounds if risk sentiment improves. The oversold list is dominated by Chinese internet and tech names alongside broader Asian and emerging market exposures, though investors are cautioned that low RSI alone is not a reliable trading signal.

03/04/2026, 12:41 PMBenzinga

Avantor Stock Down 46% This Past Year, but One Fund's $23 Million Bet Signals Turnaround Potential

Despite Avantor's stock declining 46% over the past year, Chicago-based Kinney Asset Management increased its position to 1.85 million shares worth $23.03 million, making it the fund's largest holding. The move signals confidence in the company's turnaround potential, as management authorizes a $500 million share repurchase program while the company navigates a reset with softer biopharma demand and a $785 million goodwill impairment.

01/02/2026, 1:20 PMThe Motley Fool

Portnoy Law Firm Announces Class Action on Behalf of Avantor, Inc. Investors

Avantor, Inc. faces a class action lawsuit alleging that company executives failed to disclose weakening competitive positioning and increased competitive intensity affecting its Laboratory Solutions business. The company cut guidance multiple times in 2025 after reporting weak organic sales growth. Stock prices fell significantly following each earnings announcement (16%, 15%, and 23% declines), with the third quarter results revealing that actual performance was worse than management's recent projections.

12/29/2025, 9:45 AMGlobeNewswire

Lost Money on Avantor, Inc.(AVTR)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed class action securities lawsuits against Avantor, Inc. (AVTR), Coupang, Inc. (CPNG), and DeFi Technologies (DEFT) alleging securities fraud. Avantor investors claim the company made false statements about its competitive positioning and concealed negative effects from increased competition during March 5, 2024 to October 28, 2025. Investors who suffered losses during the relevant periods can join the lawsuits at no cost.

12/26/2025, 4:56 PMGlobeNewswire

AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is seeking investors who purchased Avantor, Inc. securities between March 5, 2024, and October 28, 2025, for a class action lawsuit alleging securities fraud. The firm claims Avantor made false and misleading statements about its competitive position and struggled with increased competition, causing investor losses when the truth emerged.

12/26/2025, 9:10 AMGlobeNewswire

DEADLINE ALERT for AVTR, SNPS, KMX, INSP: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions

Law firm alerts shareholders about potential securities fraud class action lawsuits for multiple companies, highlighting alleged misleading statements and financial misrepresentations during specific time periods.

12/18/2025, 12:00 PMGlobeNewswire

Portnoy Law Firm Announces Class Action on Behalf of Avantor, Inc. Investors

Portnoy Law Firm announces a class action lawsuit against Avantor for allegedly misleading investors about competitive challenges in its Laboratory Solutions business, with stock prices declining after multiple financial result announcements revealing weak performance.

12/16/2025, 9:00 AMGlobeNewswire

AVTR DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages Avantor, Inc. Investors to Secure Counsel Before Important December 29 Deadline in Securities Class Action - AVTR

Rosen Law Firm alerts Avantor investors about a securities class action lawsuit regarding potential misrepresentations about the company's competitive positioning and business prospects during the period of March 5, 2024 to October 28, 2025.

12/14/2025, 11:23 AMGlobeNewswire

AVTR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR

Rosen Law Firm alerts Avantor investors about a securities class action lawsuit alleging misrepresentation of the company's competitive positioning and business prospects during the period of March 5, 2024 to October 28, 2025.

12/11/2025, 5:45 PMGlobeNewswire

Investors in Avantor, Inc. Should Contact The Gross Law Firm Before December 29, 2025 to Discuss Your Rights – AVTR

The Gross Law Firm has filed a class action lawsuit against Avantor, Inc. alleging the company issued false or misleading statements about its competitive positioning and business prospects between March 5, 2024 and October 28, 2025.

12/11/2025, 4:44 PMGlobeNewswire

DEADLINE ALERT for AVTR, SNPS, KMX, INSP: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions

Law firm alerts shareholders about potential securities fraud class action lawsuits for multiple companies, alleging misleading statements about business performance and prospects during specific time periods.

12/10/2025, 12:00 PMGlobeNewswire

AVTR: Kirby McInerney LLP Advises Avantor, Inc. Investors of Class Action Lawsuit

Kirby McInerney LLP is investigating a potential securities fraud class action against Avantor, alleging the company made false statements about its competitive positioning and business performance during March 5, 2024 to October 28, 2025.

12/09/2025, 6:00 PMGlobeNewswire

AVTR DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avantor, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AVTR

Rosen Law Firm is notifying Avantor investors of a potential securities class action lawsuit alleging misrepresentation of the company's competitive positioning and business prospects during the period of March 5, 2024 to October 28, 2025.

12/05/2025, 5:30 PMGlobeNewswire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR

Rosen Law Firm is notifying Avantor investors about a potential securities class action lawsuit alleging misrepresentation of the company's competitive positioning and business prospects during the period of March 5, 2024 to October 28, 2025.

12/01/2025, 2:29 PMGlobeNewswire

Peers

Statistics

More
Day Range
$9.35
$9.62
$9.35
1-Year Range
$7.41
$15.60
$9.35
Latest Close$9.35
Change
-$0.23 (-2.46%)
Volume7,390,973
Market Cap$6.4B
Shares Outstanding682.8M
P/E (TTM)-11.52
Diluted EPS (TTM)-$0.81
Enterprise Value$9.9B

Information as of 06/22/2026

Company Profile

$6.4B
Market Cap
-$551.4M
Net Income
Sector: Healthcare
Industry: Medical Instruments & Supplies
Radnor Corporate Center, Radnor, PA, United States, 19087
610 386 1700

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Key Executives

  • Corey D. Walker
  • R. Brent Jones
  • Emmanuel Ligner
  • Michael Wondrasch
  • Claudius O. Sokenu

Current Ownership Distribution

  • Institutions11.5B (66.94%)
  • Mutual Funds5.6B (32.42%)
  • Insiders110.2M (0.64%)
  • Other0 (0.00%)